Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (7): 661-667.DOI: 10.3969/j.issn.1673-8640.2024.07.008
Previous Articles Next Articles
LIN Jing1, PAN Qingqing2(), SHEN Min2, XIE Yangmin2, JIN Zhonggan3, PAN Jingjue1, LIU Jiajuan4
Received:
2023-12-08
Revised:
2024-05-15
Online:
2024-07-30
Published:
2024-07-31
CLC Number:
LIN Jing, PAN Qingqing, SHEN Min, XIE Yangmin, JIN Zhonggan, PAN Jingjue, LIU Jiajuan. Establishment and performance evaluation of candidate reference measurement procedures for serum voriconazole[J]. Laboratory Medicine, 2024, 39(7): 661-667.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.07.008
项目 | 母离子 (m/z) | 子离子 (m/z) | 碰撞电压/ V |
---|---|---|---|
伏立康唑 | |||
定量 | 350.082 | 280.946 | 28 |
定性 | 350.082 | 127.000 | 8 |
伏立康唑-2H3 | |||
定量 | 353.060 | 283.917 | 16 |
定性 | 353.060 | 130.000 | 26 |
项目 | 母离子 (m/z) | 子离子 (m/z) | 碰撞电压/ V |
---|---|---|---|
伏立康唑 | |||
定量 | 350.082 | 280.946 | 28 |
定性 | 350.082 | 127.000 | 8 |
伏立康唑-2H3 | |||
定量 | 353.060 | 283.917 | 16 |
定性 | 353.060 | 130.000 | 26 |
样本编号 | 理论值/(μg·mL-1) | 样本数/份 | 测定均值/(μg·mL-1) | 平均RSN | CV/% | 偏移/% |
---|---|---|---|---|---|---|
1 | 0.080 | 10 | 0.091 0 | 19 | 5.19 | 13.50 |
2 | 0.096 | 10 | 0.108 0 | 27 | 4.77 | 12.50 |
3 | 0.160 | 10 | 0.167 0 | 44 | 2.17 | 4.50 |
样本编号 | 理论值/(μg·mL-1) | 样本数/份 | 测定均值/(μg·mL-1) | 平均RSN | CV/% | 偏移/% |
---|---|---|---|---|---|---|
1 | 0.080 | 10 | 0.091 0 | 19 | 5.19 | 13.50 |
2 | 0.096 | 10 | 0.108 0 | 27 | 4.77 | 12.50 |
3 | 0.160 | 10 | 0.167 0 | 44 | 2.17 | 4.50 |
样本 类型 | 加标浓度/ (μg·mL-1) | 均值/ (μg·mL-1) | 平均回收率/% | CV/% |
---|---|---|---|---|
低浓度 | 0.801 | 0.789 | 98.48 | 0.87 |
中浓度 | 4.007 | 3.897 | 97.26 | 0.21 |
高浓度 | 8.010 | 7.847 | 97.96 | 0.27 |
样本 类型 | 加标浓度/ (μg·mL-1) | 均值/ (μg·mL-1) | 平均回收率/% | CV/% |
---|---|---|---|---|
低浓度 | 0.801 | 0.789 | 98.48 | 0.87 |
中浓度 | 4.007 | 3.897 | 97.26 | 0.21 |
高浓度 | 8.010 | 7.847 | 97.96 | 0.27 |
样本类型 | 批内 | 批间 | |||||
---|---|---|---|---|---|---|---|
均值/(μg·mL-1) | s/(μg·mL-1) | CV/% | 均值/(μg·mL-1) | s/(μg·mL-1) | CV/% | ||
低浓度 | 0.789 | 0.007 | 0.87 | 0.782 | 0.012 | 1.59 | |
0.768 | 0.005 | 0.64 | |||||
0.790 | 0.006 | 0.75 | |||||
中浓度 | 3.897 | 0.008 | 0.21 | 3.956 | 0.052 | 1.32 | |
3.996 | 0.020 | 0.50 | |||||
3.976 | 0.021 | 0.53 | |||||
高浓度 | 7.847 | 0.021 | 0.27 | 7.878 | 0.093 | 1.18 | |
7.805 | 0.060 | 0.77 | |||||
7.983 | 0.047 | 0.59 |
样本类型 | 批内 | 批间 | |||||
---|---|---|---|---|---|---|---|
均值/(μg·mL-1) | s/(μg·mL-1) | CV/% | 均值/(μg·mL-1) | s/(μg·mL-1) | CV/% | ||
低浓度 | 0.789 | 0.007 | 0.87 | 0.782 | 0.012 | 1.59 | |
0.768 | 0.005 | 0.64 | |||||
0.790 | 0.006 | 0.75 | |||||
中浓度 | 3.897 | 0.008 | 0.21 | 3.956 | 0.052 | 1.32 | |
3.996 | 0.020 | 0.50 | |||||
3.976 | 0.021 | 0.53 | |||||
高浓度 | 7.847 | 0.021 | 0.27 | 7.878 | 0.093 | 1.18 | |
7.805 | 0.060 | 0.77 | |||||
7.983 | 0.047 | 0.59 |
放置条件 | 理论值/(μg·mL-1) | 实测值/(μg·mL-1) | 回收率/ % |
---|---|---|---|
室温放置 | |||
4 h | 0.801 | 0.784 | 97.88 |
8 h | 0.801 | 0.778 | 97.13 |
-20 ℃下反复冻融 | |||
1次 | 0.801 | 0.775 | 96.75 |
2次 | 0.801 | 0.766 | 95.63 |
3次 | 0.801 | 0.783 | 97.75 |
4次 | 0.801 | 0.789 | 98.50 |
5次 | 0.801 | 0.773 | 96.50 |
放置条件 | 理论值/(μg·mL-1) | 实测值/(μg·mL-1) | 回收率/ % |
---|---|---|---|
室温放置 | |||
4 h | 0.801 | 0.784 | 97.88 |
8 h | 0.801 | 0.778 | 97.13 |
-20 ℃下反复冻融 | |||
1次 | 0.801 | 0.775 | 96.75 |
2次 | 0.801 | 0.766 | 95.63 |
3次 | 0.801 | 0.783 | 97.75 |
4次 | 0.801 | 0.789 | 98.50 |
5次 | 0.801 | 0.773 | 96.50 |
放置条件 | 理论值/(μg·mL-1) | 实测值/(μg·mL-1) | 回收率/ % |
---|---|---|---|
室温放置 | |||
4 h | 0.801 | 0.792 | 98.88 |
8 h | 0.801 | 0.786 | 98.13 |
12 h | 0.801 | 0.782 | 97.63 |
24 h | 0.801 | 0.773 | 96.50 |
进样器(8 ℃) | |||
4 h | 0.801 | 0.791 | 98.75 |
8 h | 0.801 | 0.797 | 99.50 |
12 h | 0.801 | 0.781 | 97.50 |
24 h | 0.801 | 0.768 | 95.88 |
放置条件 | 理论值/(μg·mL-1) | 实测值/(μg·mL-1) | 回收率/ % |
---|---|---|---|
室温放置 | |||
4 h | 0.801 | 0.792 | 98.88 |
8 h | 0.801 | 0.786 | 98.13 |
12 h | 0.801 | 0.782 | 97.63 |
24 h | 0.801 | 0.773 | 96.50 |
进样器(8 ℃) | |||
4 h | 0.801 | 0.791 | 98.75 |
8 h | 0.801 | 0.797 | 99.50 |
12 h | 0.801 | 0.781 | 97.50 |
24 h | 0.801 | 0.768 | 95.88 |
项目 | 量值 | 标准不确定度 | 相对标准不确定度/% |
---|---|---|---|
A/A内标 | 1.091 | 0.009 | 0.82 |
fc | 1.000 | 0.002 | 0.20 |
fm | 1.000 | 0.013 | 1.30 |
k | 0.363 38 | 0.001 | 0.28 |
b | -0.028 33 | 0 | 0 |
重复性/(μg·mL-1) | 2.90 | 0.009 | 0.31 |
测定均值(μg·mL-1) | 2.90 | ||
合成相对标准不确定度/% | 1.67 | ||
扩展因子 | 2 | ||
相对扩展不确定度/% | 3.34 |
项目 | 量值 | 标准不确定度 | 相对标准不确定度/% |
---|---|---|---|
A/A内标 | 1.091 | 0.009 | 0.82 |
fc | 1.000 | 0.002 | 0.20 |
fm | 1.000 | 0.013 | 1.30 |
k | 0.363 38 | 0.001 | 0.28 |
b | -0.028 33 | 0 | 0 |
重复性/(μg·mL-1) | 2.90 | 0.009 | 0.31 |
测定均值(μg·mL-1) | 2.90 | ||
合成相对标准不确定度/% | 1.67 | ||
扩展因子 | 2 | ||
相对扩展不确定度/% | 3.34 |
项目 | 量值 | 标准不确定度 | 相对标准不 确定度/% |
---|---|---|---|
A/A内标 | 4.440 | 0.031 | 0.70 |
fc | 1.000 | 0.002 | 0.20 |
fm | 1.000 | 0.013 | 1.30 |
k | 0.363 38 | 0.001 | 0.28 |
b | -0.028 33 | 0 | 0 |
重复性/(μg·mL-1) | 11.74 | 0.049 | 0.42 |
测定均值/(μg·mL-1) | 11.74 | ||
合成相对标准不确定度/% | 1.62 | ||
扩展因子 | 2 | ||
相对扩展不确定度/% | 3.24 |
项目 | 量值 | 标准不确定度 | 相对标准不 确定度/% |
---|---|---|---|
A/A内标 | 4.440 | 0.031 | 0.70 |
fc | 1.000 | 0.002 | 0.20 |
fm | 1.000 | 0.013 | 1.30 |
k | 0.363 38 | 0.001 | 0.28 |
b | -0.028 33 | 0 | 0 |
重复性/(μg·mL-1) | 11.74 | 0.049 | 0.42 |
测定均值/(μg·mL-1) | 11.74 | ||
合成相对标准不确定度/% | 1.62 | ||
扩展因子 | 2 | ||
相对扩展不确定度/% | 3.24 |
[1] | PATTERSON T F, THOMPSON G R 3rd, DENNING D W, et al. Practice guidelines for the diagnosis and management of aspergillosis:2016 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2016, 63(4):e1-e60. |
[2] | PAPPAS P G, KAUFFMAN C A, ANDES D R, et al. Clinical practice guideline for the management of candidiasis:2016 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2016, 62(4):e1-e50. |
[3] | JIN H, WANG T, FALCIONE B A, et al. Trough concentration of voriconazole and its relationship with efficacy and safety:a systematic review and meta-analysis[J]. J Antimicrob Chemother, 2016, 71(7):1772-1785. |
[4] |
HOENIGL M, DUETTMANN W, RAGGAM R B, et al. Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies[J]. Antimicrob Agents Chemother, 2013, 57(7):3262-3267.
DOI PMID |
[5] |
MORIYAMA B, OBENG A O, BARBARINO J, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C19 and voriconazole therapy[J]. Clin Pharmacol Ther, 2017, 102(1):45-51.
DOI PMID |
[6] |
林志强, 张清泉, 陈婷婷. 伏立康唑的治疗药物监测:国内外相关指南概览[J]. 药物不良反应杂志, 2020, 22(7):409-415.
DOI |
[7] | WANG T, XIE J, WANG Y, et al. Pharmacokinetic and pharmacodynamic properties of oral voriconazole in patients with invasive fungal infections[J]. Pharmacotherapy, 2015, 35 (9):797-804. |
[8] |
伍三兰, 蔡华丹, 赵妮, 等. 伏立康唑致肝毒性临床特点[J]. 医药导报, 2018, 37(3):387-390.
DOI |
[9] | 王晓梅, 张林. 84例伏立康唑不良反应分析[J]. 药物不良反应与不良事件, 2017, 36(12):1432-1436. |
[10] | CHEN K, ZHANG X, KE X, et al. Individualized medication of voriconazole:a practice guideline of the Division of Therapeutic Drug Monitoring,Chinese Pharmacological Society[J]. Ther Drug Monit, 2018, 40(6):663-674. |
[11] | 叶健, 卓广超, 等. HPLC法测定人血浆中伏立康唑的浓度[J]. 中国药房, 2021, 32(20):2525-2529. |
[12] | 马霖, 孙加琳, 李恩泽, 等. LC-MS-MS法同时测定人血浆中伏立康唑和替加环素的浓度[J]. 中国临床药理学杂志, 2019, 35(24):3237-3240. |
[13] | LI X, LI W, LI M, et al. Correlation between enzyme multiplied immunoassay technique and high-performance liquid chromatography in the quantification of voriconazole in a paediatricpopulation[J]. Scand J Clin Lab Invest, 2021, 81(2):121-126. |
[14] | 陈君, 黄春新, 王敏. 超高效液相色谱法测定人血清中伏立康唑血药浓度与临床应用[J]. 海南医学, 2021, 32(2):173-176. |
[15] | Clinical and Laboratory Standards Institute. Liquid chromatography-mass spectrometry methods[S]. C62-A,CLSI, 2014. |
[16] | Clinical and Laboratory Standards Institute. Mass spectrometry in the clinical laboratory:general principles and guidance[S]. C50-A,CLSI, 2007. |
[17] |
沈敏, 杨晓东, 王琳, 等. 血清总同型半胱氨酸候选参考测量程序(液相色谱串联质谱法)的建立及性能评估[J]. 检验医学, 2018, 33(11):1018-1025.
DOI |
[18] |
EI-KHOURY J M, BUNCH D R, REINEKS E, et al. A simple and fast liquid chromatography-tandem mass spectrometry method for measurement of underivatized L-arginine,symmetric dimethylarginine,and asymmetric dimethylarginine and establishment of the reference ranges[J]. Anal Bioanal Chem, 2012, 402(2):771-779.
DOI PMID |
[19] | International Organization for Standardization. Guide to the expression of uncertainty in measurement[S]. 1995. |
[20] | 张元元, 刘维, 周从亚, 等. LC-MS/MS同时测定人血浆中伏立康唑和泊沙康唑的浓度[J]. 中国临床药理学杂志, 2020, 36(12):1697-1700. |
[21] | 钟皎, 郝琨, 裴泽军. UPLC-MS/MS法测定人血浆中伏立康唑的浓度及其临床应用[J]. 中国药房, 2016, 27(29):4064-4066. |
[22] | 刘洋, 邱婷婷, 张弨. HPLC-MS/MS法测定人血浆中伏立康唑浓度[J]. 中国临床药理学杂志, 2018, 34(10):1222-1225. |
[1] | TANG Ningbo, LIU Guancai, LIU Xiaoyu, YANG Fengfan, GONG Zhimei, SUN Keqi. Establishment and evaluation for the determination of serum digitoxin as a candidate reference method [J]. Laboratory Medicine, 2022, 37(5): 456-462. |
[2] | SONG Ying, HAN Jiaojiao, ZHAO Qiang, XU Chong. Establishment and performance evaluation of peripheral blood leukocyte classification reference method by flow cytometry [J]. Laboratory Medicine, 2022, 37(12): 1190-1195. |
[3] | LI Qing, JU Yi, TANG Liping, JIN Zhonggan, SUN Hewei. Application of candidate reference method of apolipoprotein A1 and apolipoprotein B in external quality assessment [J]. Laboratory Medicine, 2021, 36(3): 259-262. |
[4] | SUN Hewei, JU Yi, ZHU Lingfeng, LI Qing, JIN Zhonggan, ZHANG Sujie. Isotope dilution liquid chromatography tandem mass spectrometry candidate reference method for serum testosterone [J]. Laboratory Medicine, 2021, 36(10): 1064-1069. |
[5] | ZOU Jihua, LI Quanle, SHEN Min, ZHANG Man, YANG Xiaodong, TU Minmin, FENG Dongfang, SUN Hongna. Establishment and performance evaluation of candidate reference measurement procedure for serum aldosterone by liquid chromatography-tandem mass spectrometry [J]. Laboratory Medicine, 2020, 35(8): 811-817. |
[6] | JIN Zhonggan, JU Yi, ZHANG Sujie, LI Qing, OU Yuanzhu, YU Xiaoxuan, SUN Hewei, FAN Xiaoyu, YU Keying. Preliminary study on the application of glucose reference method to determine the target value for EQA samples [J]. Laboratory Medicine, 2020, 35(11): 1190-1193. |
[7] | JIN Zhonggan, JU Yi, LI Qing, TANG Liping, YU Xiaoxuan, LIU Wenbin, OU Yuanzhu. Analysis on the results of creatinine,uric acid and urea determination trueness verification in Shanghai,2016 [J]. Laboratory Medicine, 2018, 33(4): 348-352. |
[8] | GAO Dongtian, SHEN Aihua. Roles of GM test and G test for the diagnosis of invasive pulmonary fungal infection and its clinical treatment efficiency [J]. Laboratory Medicine, 2018, 33(1): 44-49. |
[9] | XU Lei, WANG Qing, ZHU Peichao, MIAO Yingbo, SONG Ying. Primary study on the reference method for hemoglobin determination [J]. Laboratory Medicine, 2017, 32(8): 709-712. |
[10] | XU Liming, WANG Zhicheng, CAI Feng. Evaluation of TEST1 automated sedimentation analyzer and establishment of the reference ranges of erythrocyte sedimentation rate for healthy subjects in Shanghai [J]. Laboratory Medicine, 2017, 32(3): 202-207. |
[11] | LI Qing, JU Yi, JIN Zhonggan, YU Xiaoxuan, OU Yuanzhu, TANG Liping, WANG Meijuan, LIU Wenbin. IFCC reference methods on the determination of glycated hemoglobin A1c and laboratory network inter-comparison [J]. Laboratory Medicine, 2016, 31(7): 607-609. |
[12] | XU Lei, WANG Qing, MIAO Yingbo, SONG Ying, WANG Guofei, ZHU Peichao, GUO Xiaojun. Primary experimental study on the reference method for the counting of red blood cells and white blood cells [J]. Laboratory Medicine, 2015, 30(6): 641-645. |
[13] | GUO Xiaojun, WANG Qing, SONG Ying, MAIO Yingbo, XU Lei. Uncertainty evaluation on the reference method of leukocyte counts for fresh blood [J]. Laboratory Medicine, 2015, 30(5): 512-516. |
[14] | JIN Zhonggan, JU Yi, TANG Liping, WANG Meijuan, LIU Wenbin, LI Qing, OU Yuanzhu, YU Xiaoxuan. Establishment and application of serum creatinine reference method in accuracy survey [J]. Laboratory Medicine, 2015, 30(11): 1070-1073. |
[15] | WU Lishan, CHEN Shufen, HU Zhibao, SHEN Min, ZHOU Jun.. Verification on the result accuracy of ALP by two routine measurement systems according to IFCC reference method [J]. Laboratory Medicine, 2015, 30(1): 44-48. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||